On February 18, 2022, the Quebec Court of Appeal ruled that two of the three major proposed changes ... Read More
News
22
Feb2022
14
Feb2022
This is a reminder to patentees of their filing requirements respecting revenues and development expenditures. These filing requirements ... Read More
31
Jan2022
The Ontario Ministry of Health has recently updated the Ontario Guidelines for Drug Submission and Evaluation (Guidelines). In ... Read More
17
Dec2021
On October 28th, 2021, PMPRB provided their first update to the Notice & Comment that was issued on ... Read More
17
Dec2021
Consultation on the Proposed Framework for a Potential Pan-Canadian Formulary will be open for feedback from January 11 - February 25, 2022. A discussion paper ... Read More
17
Dec2021
On December 16, 2021, CADTH provided an update regarding CADTH’s drug review programs.
A. ... Read More
29
Jun2021
This morning, June 29th, 2021, Health Canada announced an additional 6-month delay in implementation of the Patented Medicines ... Read More
14
Jun2021
Information regarding the PMPRB guidelines and the upcoming webinar can be found here. Registration is required to ... Read More